Selective interactome vulnerability across the Alzheimer’s disease spectrum
阿尔茨海默病谱系中的选择性相互作用组脆弱性
基本信息
- 批准号:10746269
- 负责人:
- 金额:$ 116.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:Affinity ChromatographyAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAutopsyBindingBiochemicalBioinformaticsBiologicalBiologyBrainBrain regionCell CommunicationCell CycleCell modelCell physiologyCellsCellular biologyCerebellumClinicalCommunitiesComplementComplexDataData AnalyticsData SetDefectDepositionDevelopmentDiagnosticDiseaseDisease ProgressionElementsEnvironmental Risk FactorEventExposure toFunctional disorderFundingGenderGeneticGenetic Predisposition to DiseaseHeat-Shock Proteins 90HippocampusImpaired cognitionIndividualInduced pluripotent stem cell derived neuronsInflammationInvestigationLinkMapsMass Spectrum AnalysisMeasuresMediatingMetabolismMethodsMiningModificationMolecular BiologyMolecular ChaperonesMolecular ConformationMultiprotein ComplexesNatureNeurodegenerative DisordersNeurogliaNeuronsOutcomeOutputPathologicPathway interactionsPatientsPhenotypePost Translational Modification AnalysisPost-Translational Protein ProcessingProcessProteinsProteomeSiteSpecificityStressStructureSynaptic plasticitySystemTestingTherapeuticTransgenic MiceTranslationsValidationaxon guidancebrain cellbrain circuitrybrain tissueconformerconnectomecrosslinkeffective therapyfrontal lobeinnovationinsightinterestmembermultidisciplinarynetwork dysfunctionnovelprotein protein interactionproteotoxicityscaffoldspatiotemporalstressorstructural determinantstherapeutic development
项目摘要
ABSTRACT
Mechanisms underlying selective vulnerability from cells to networks across the Alzheimer's disease (AD)
spectrum remain unknown, limiting our understanding of disease and hampering development of effective
therapies. We propose to identify protein-protein interaction (PPI) network dysfunctions in brain cells and regions
as a gateway to selective vulnerability mechanisms in AD. To gain systems level insights, we propose to leverage
our discoveries in stress biology linking interactome network perturbations to the formation of long-lived
oligomeric scaffolds termed epichaperomes, and to employ a novel `omics platform called epichaperomics that
provides direct information on PPI network changes. Preliminary studies indicate epichaperomes change how
thousands of proteins interact and negatively impact PPI networks important for neuronal function, including
synaptic plasticity, cell-to-cell communication, protein translation, cell cycle re-entry, axon guidance, metabolic
processes and inflammation, leading to cell and connectome-wide dysfunction and cognitive decline. Parallel
studies in transgenic mice and iPSC-derived neurons demonstrate epichaperome formation is a key event that
negatively impacts cellular function, from early prodromal disease stages and throughout disease progression.
Preliminary results in transgenic mice and postmortem AD brains suggest epichaperome formation occurs
principally within vulnerable brain cells and regions. Accordingly, we hypothesize epichaperome formation, and
in turn of epichaperome-mediated PPI network imbalances, over decades, not only results in defects within
intrinsic neuronal proteins and protein pathways but also intercellularly, where it disrupts intrinsic network
connectivity of cells and of brain circuits. We posit vulnerable neurons and brain regions have a higher propensity
to accumulate epichaperomes, and epichaperome-mediated dysfunctions. In accordance with NOT-AG-21-040,
we propose to uncover mechanisms of PPI dysfunctions within individual brain cells and regions as a portal into
selective vulnerability in AD, which remains unknown and a key missing piece. We aim to i) investigate
mechanisms that enable (i.e., epichaperomes, Aim 1) and ii) those that execute (i.e., impacted proteins and
protein pathways, Aim 2) context-specific dysfunctions in PPI networks. As a key element in linking stressors-to-
phenotype, we aim to uncover cell- and region-specific vulnerabilities within PPI networks induced by individual
stressors (Aim 3). Results provide first-of-a-kind insights into the spatio-temporal formation and distribution of
epichaperomes across the AD spectrum and their relationship to clinical, pathologic, and genetic vulnerabilities.
Outcomes are critical proteome-wide insights into interactome vulnerabilities, both on the nature and trajectory
within vulnerable brain cells and brain regions. Raw datasets and data analytics will be deposited directly into
free access sites for mining and hypothesis testing by members of the scientific community. In addition to defining
technically challenging mechanistic insights into selective AD vulnerabilities, innovation includes diagnostics and
therapeutics, as epichaperome-mediated dysfunctions are both imageable and targetable.
摘要
阿尔茨海默病(AD)中从细胞到网络的选择性脆弱性机制
谱仍然未知,限制了我们对疾病的了解,阻碍了有效治疗的发展。
治疗我们建议识别脑细胞和区域中的蛋白质-蛋白质相互作用(PPI)网络功能障碍
作为AD中选择性漏洞机制的网关。为了获得系统级的见解,我们建议利用
我们在应激生物学中的发现将相互作用组网络扰动与长寿命
寡聚支架称为epichaperomes,并采用一种新的`组学平台称为epichaperomics,
提供有关PPI网络更改的直接信息。初步研究表明epichaperomes如何改变
数以千计的蛋白质相互作用并对PPI网络产生负面影响,这些网络对神经元功能至关重要,包括
突触可塑性,细胞间通讯,蛋白质翻译,细胞周期再进入,轴突导向,代谢
过程和炎症,导致细胞和连接体功能障碍和认知能力下降。平行
在转基因小鼠和iPSC衍生的神经元中的研究表明epichaperome形成是一个关键事件,
从早期前驱疾病阶段和整个疾病进展对细胞功能产生负面影响。
转基因小鼠和AD死后大脑的初步结果表明,
主要是在脆弱的脑细胞和区域内。因此,我们假设epichaperome形成,
反过来,epichaperome介导的PPI网络失衡,几十年来,不仅导致内部缺陷,
内在神经元蛋白和蛋白通路,但也在细胞间,在那里它破坏内在网络
细胞和大脑回路的连接。我们保护脆弱的神经元和大脑区域有更高的倾向
积累epichaperomes和epichaperome-mediated功能障碍。根据NOT-AG-21-040,
我们建议揭示个别脑细胞和区域内PPI功能障碍的机制,
AD的选择性脆弱性,这仍然是未知的,也是一个关键的缺失部分。我们的目标是i)调查
能够实现(即,epichaperomes,目标1)和ii)那些执行(即,影响蛋白质和
蛋白质通路,目标2)PPI网络中的特定功能障碍。作为联系压力源和
表型,我们的目标是揭示细胞和区域特定的脆弱性PPI网络诱导的个人
压力源(目标3)。结果提供了第一个一类的洞察时空的形成和分布,
epichaperomes在整个AD谱及其与临床,病理和遗传脆弱性的关系。
结果是关键的蛋白质组范围的见解相互作用组的脆弱性,无论是在性质和轨迹
脆弱的脑细胞和脑区。原始数据集和数据分析将直接存入
科学界成员可免费访问网站进行挖掘和假设检验。除了定义
在技术上具有挑战性的机械洞察选择性AD漏洞,创新包括诊断和
治疗,因为epichaperome介导的功能障碍是可成像的和可靶向的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABRIELA CHIOSIS其他文献
GABRIELA CHIOSIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABRIELA CHIOSIS', 18)}}的其他基金
[18F]-PU-AD epichaperome PET imaging probe
[18F]-PU-AD外表面组PET成像探针
- 批准号:
10445594 - 财政年份:2022
- 资助金额:
$ 116.55万 - 项目类别:
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
性别差异对 AD 谱系中相互作用组功能障碍轨迹的影响
- 批准号:
10491240 - 财政年份:2021
- 资助金额:
$ 116.55万 - 项目类别:
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
性别差异对 AD 谱系中相互作用组功能障碍轨迹的影响
- 批准号:
10633261 - 财政年份:2021
- 资助金额:
$ 116.55万 - 项目类别:
Selective interactome vulnerability across the Alzheimer’s disease spectrum
阿尔茨海默病谱系中的选择性相互作用组脆弱性
- 批准号:
10386016 - 财政年份:2021
- 资助金额:
$ 116.55万 - 项目类别:
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
性别差异对 AD 谱系中相互作用组功能障碍轨迹的影响
- 批准号:
10300853 - 财政年份:2021
- 资助金额:
$ 116.55万 - 项目类别:
Translating Stress Response Targeted Therapy for B-Cell Lymphomas
将应激反应靶向治疗转化为 B 细胞淋巴瘤
- 批准号:
8997374 - 财政年份:2016
- 资助金额:
$ 116.55万 - 项目类别:
Project 2: Development of grp94-selective Inhibitors for Cancer
项目2:grp94选择性癌症抑制剂的开发
- 批准号:
8934514 - 财政年份:2015
- 资助金额:
$ 116.55万 - 项目类别:
Biomarkers for predicting response to Hsp90 therapy
用于预测 Hsp90 治疗反应的生物标志物
- 批准号:
8685204 - 财政年份:2013
- 资助金额:
$ 116.55万 - 项目类别:
Biomarkers for predicting response to Hsp90 therapy
用于预测 Hsp90 治疗反应的生物标志物
- 批准号:
9054085 - 财政年份:2013
- 资助金额:
$ 116.55万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 116.55万 - 项目类别:
Operating Grants